DOT1L and melanoma: To characterize the molecular characteristics of Dot1l-null melanoma, we measured the mRNA expression of neural crest development genes, tumor-suppressor genes, and oncogenes in melanoma development by quantitative reverse-transcriptase PCR (qRT-PCR).